CLNNW

Clene Warrant (CLNNW)

About Clene Warrant (CLNNW)

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.

Details

Daily high
$0.04
Daily low
$0.03
Price at open
$0.03
52 Week High
$0.09
52 Week Low
$0.02
Market cap
--
Dividend yield
0.00%
Volume
4,010
Avg. volume
7,155
P/E ratio
--

Clene Warrant News

Details

Daily high
$0.04
Daily low
$0.03
Price at open
$0.03
52 Week High
$0.09
52 Week Low
$0.02
Market cap
--
Dividend yield
0.00%
Volume
4,010
Avg. volume
7,155
P/E ratio
--